Sutimco International Inc (SUTI) 0.0001 $SUTI SutimCo

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sutimco International Inc (SUTI) 0.0001 $SUTI

SutimCo Inc.'s Share Buy Back and Shareholders Updates
ACCESSWIRE - Mon Aug 03, 8:15AM CDT
CHEYENNE, WY / ACCESSWIRE / August 3, 2015 / SutimCo Inc. (PINKSHEETS: SUTI) ("The Company" Today, the CEO and management of the company make the following updates to shareholders:

SutimCo Inc. Share Buy Back and Shareholders Updates.
ACCESSWIRE - Fri Jul 31, 1:06PM CDT
CHEYENNE, WY / ACCESSWIRE / July 31, 2015 / SutimCo Inc. (OTC PK: SUTI) ("The Company"

SutimCo Inc. New Acquisition Shareholders Updates
ACCESSWIRE - Tue Jul 28, 12:00PM CDT
CHEYENNE, WY / ACCESSWIRE / July 28, 2015 / SutimCo Inc. (PINKSHEETS:SUTI) ("The Company" Today, the CEO and Management of the company would like to provide shareholders with an update on the progress of a previously announced acquisition agreement. On May 22, 2015 the company issued a press release with respect to an acquisition with DMND Inc. www.dmndinc.net. After much negotiation, management is proud to announce that a purchase agreement was recently signed and finalized. The terms of the sale include SutimCo acquiring a block of Class A Preferred and 144 common stock in exchange for 150,000,000 shares of SutiMco International Inc., 144 common stock. The shares acquired equal over 100% of the common voting rights of DMND INC. DMND Inc., located in Newport Beach, California, are manufacturers of diverse hemp products and have the licensing and manufacturing rights for distribution. This will allow SutimCo to have the opportunity to brand such products. DMND Inc. will be our wholly owned subsidiary. A share exchange was the best method for this particular deal and was the best structure for our company and shareholders. The successful conclusion of this purchase agreement is a prime example of SutimCos mission to seek partnerships with established brands and provide venture capital funds to manufacturers, growers and retail franchise operations. The company continues to concentrate its efforts on aggressive acquisitions. - Jorge Saenz, SutimCo Inc. CEO.

SutimCo International Inc. New Dividend and Shareholders Updates.
ACCESSWIRE - Wed Jul 15, 8:15AM CDT
DALLAS, TX / ACCESSWIRE / July 15, 2015 / SutimCo International Inc. (OTC PK: SUTI) ("The Company" Today, the CEO and Management of the company are pleased to announce a material event with respect to the status of the pending Sutimco (SUTI) dividend for the ProTek Capital (PRPM) shareholders. As we await confirmation of final approval for both the record date and distribution date from FINRA, management would like to take the opportunity to disclose to shareholders that majority shareholders, Edward Vakser and affiliates, have made agreement to retire their (approximate 300 million) dividend shares that they were to receive from this corporate action. All of their dividend shares will be returned to the company treasury.

SUTI Inc., Current Information Disclosure, and a Form 8K Filing
ACCESSWIRE - Fri Jul 10, 9:00AM CDT
DALLAS, TX / ACCESSWIRE / July 10, 2015 / SutimCo International Inc. (PINKSHEETS: SUTI) ("The Company" has completed the funding for the strategic partners in Oregon, Canna and the City. The 8K filing is attached.

SUTI Inc., Fulfills the Definitive Agreement with Canna and the City by Funding the Contract
ACCESSWIRE - Wed Jul 08, 8:16AM CDT
DALLAS, TX / ACCESSWIRE / July 8, 2015 / SutimCo International Inc. ("The Company" (OTC PK: SUTI) (PINKSHEETS: SUTI), the company has completed the funding for the strategic partners in Oregon, Canna and the City. The full 8K filings will post this Friday July 10th, and company will release updates for the website with the information and pictures of the dispensary and all the relevant information.

SutimCo Inc. Signed a Definitive Agreement and Shareholders Updates
ACCESSWIRE - Thu Jul 02, 10:14AM CDT
DALLAS, TX / ACCESSWIRE / July 2, 2015 / SutimCo Inc. (PINKSHEETS: SUTI) ("The Company" has signed a definitive agreement with the new strategic partners in Oregon. The company will release and update the website with the information and pictures of the dispensary and all the relevant information.

Sutimco: New Business and Products Developments.
ACCESSWIRE - Fri Jun 26, 11:15AM CDT
DALLAS, TX / ACCESSWIRE / June 26, 2015 / SutimCo Inc. (OTC PK: SUTI) ("The Company" Today, the company and the management announces following shareholders updates:

SutimCo Inc.'s New Funding Structure for Market Expansion
ACCESSWIRE - Fri Jun 19, 8:15AM CDT
DALLAS, TX / ACCESSWIRE / June 19, 2015 / SutimCo Inc. (PINKSHEETS: SUTI) ("The Company" The company is on a fast track to empower its management and the new CEO with a structured funding via line of credit and asset based lending.

SutimCo Inc. Provides Update on New Acquisition and Market Expansion
ACCESSWIRE - Tue Jun 16, 10:21AM CDT
DALLAS, TX / ACCESSWIRE / June 16, 2015 / SutimCo Inc. (OTC PK: SUTI) ("The Company" The company is pleased to announce it has entered a preliminary agreement to negotiate with a medical marijuana dispensary in Portland, Or. The company will offer a LOI to start formal negotiations for a partnership. An update will follow on the results.

SutimCo's New CEO Provides Shareholders Updates
ACCESSWIRE - Wed Jun 10, 8:26AM CDT
DALLAS, TX / ACCESSWIRE / June 10, 2015 / SutimCo Inc. (OTC PK: SUTI) ("The Company"

Protek Capital Shareholders Update From New CEO
ACCESSWIRE - Wed Jun 10, 8:11AM CDT
DALLAS, TX / ACCESSWIRE / June 10, 2015 / ProTek Capital Inc. (OTCPK: PRPM), today the company announces first public address to the shareholders by its new CEO, Jorge Luis Saenz.

Sutimco Inc. Welcomes a New CEO
ACCESSWIRE - Thu Jun 04, 8:20AM CDT
DALLAS, TX / ACCESSWIRE / June 4, 2015 / SutimCo Inc. (PINKSHEETS: SUTI) ("The Company"The company is pleased to announce the hiring of a new CEO, Jorge Luis Saenz. Mr. Saenz has an impressive resume and a great track record in Cannabis and Marijuana market sectors. He is not only a great executive and content expert in MJ industries, but he is also a shareholder in our company.

New Chairman and a Corporate Spin Off
ACCESSWIRE - Wed Apr 15, 8:01AM CDT
DALLAS, TX / ACCESSWIRE / April 15, 2015 / SutimCo Inc. (PINKSHEETS:SUTI) ("The Company" Today, the new CEO and Management of the company announce the addition of Mr.Scott Weinert to the Board of Directors and the new Chairman of the Board.

SUTIMCO International Inc., Decrease in shares Issued and Outstanding
ACCESSWIRE - Fri Apr 10, 8:31AM CDT
DALLAS, TX / ACCESSWIRE / April 10, 2015 / SutimCo Inc. (PINKSHEETS:SUTI) ("The Company"Today, the new CEO and Management of the company announce the retirement of 500,000,000 (Five Hundred Million) shares of the company's current issued and outstanding shares.

SUTIMCO International Inc. New Management and New Developments for the Company
ACCESSWIRE - Mon Apr 06, 6:15PM CDT
DALLAS, TX / ACCESSWIRE / April 6, 2015 / SutimCo Inc. (PINKSHEET:SUTI) ("The Company"

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading